ESR1 mutations in circulating plasma tumor DNA from metastatic breast cancer patients

PURPOSE: Mutations in the estrogen receptor-alpha (ER) gene, ESR1, have been identified in breast cancer metastases after progression on endocrine therapies. Due to limitations of metastatic biopsies, the reported frequency of ESR1 mutations may be underestimated. Here, we show a high frequency of E...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Chu, David, Paoletti, Costanza, Gersch, Christina, VanDenBerg, Dustin A., Zabransky, Daniel J., Cochran, Rory L., Wong, Hong Yuen, Toro, Patricia Valda, Cidado, Justin, Croessmann, Sarah, Erlanger, Bracha, Cravero, Karen, Kyker-Snowman, Kelly, Button, Berry, Parsons, Heather, Dalton, W. Brian, Gillani, Riaz, Medford, Arielle, Aung, Kimberly, Tokudome, Nahomi, Chinnaiyan, Arul M., Schott, Anne, Robinson, Dan, Jacks, Karen S., Lauring, Josh, Hurley, Paula, Hayes, Daniel F., Rae, James, Park, Ben Ho
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4993201/
https://ncbi.nlm.nih.gov/pubmed/26261103
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-15-0943
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados